CLINICAL CHEMISTRY Journal
Overview
publication venue for
- Commutability Limitations Influence Quality Control Results with Different Reagent Lots. 57:76-83. 2011
- Optimization of Transrenal DNA Analysis: Detection of Fetal DNA in Maternal Urine. 55:723-729. 2009
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Clinical Practice: Quality Requirements. 54:E1-E10. 2008
- Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: Sources of sample bias. 54:44-52. 2008
- SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer. 54:53-60. 2008
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements.. 54:e1-e10. 2008
- Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. 51:102-112. 2005
- Enhancement of Sensitivity and Resolution of Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometric Records for Serum Peptides Using Time-Series Analysis Techniques. 51:65-74. 2005
- Urinary protein profiling of bladder cancer patients by decision tree classification of mass spectral data 2004
- Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients.. 48:1835-43. 2002
- An Unusual Electrophoresis 2014
- The "omics" haystack: Defining sources of sample bias in expression profiling 2005
- Protein Profiling in Urine for the Diagnosis of Bladder Cancer 2004
Identity
International Standard Serial Number (ISSN)
- 0009-9147
Electronic International Standard Serial Number (EISSN)
- 1530-8561